These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 18831981)
1. A model for venom-induced consumptive coagulopathy in snake bite. Tanos PP; Isbister GK; Lalloo DG; Kirkpatrick CM; Duffull SB Toxicon; 2008 Dec; 52(7):769-80. PubMed ID: 18831981 [TBL] [Abstract][Full Text] [Related]
2. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom. Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ; Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016 [TBL] [Abstract][Full Text] [Related]
4. Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP-17). Gulati A; Isbister GK; Duffull SB Toxicon; 2013 Jan; 61():94-104. PubMed ID: 23151381 [TBL] [Abstract][Full Text] [Related]
5. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms. Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586 [TBL] [Abstract][Full Text] [Related]
6. Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom. Zdenek CN; Hay C; Arbuckle K; Jackson TNW; Bos MHA; Op den Brouw B; Debono J; Allen L; Dunstan N; Morley T; Herrera M; Gutiérrez JM; Williams DJ; Fry BG Toxicol In Vitro; 2019 Aug; 58():97-109. PubMed ID: 30910521 [TBL] [Abstract][Full Text] [Related]
8. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. Isbister GK; Duffull SB; Brown SG; QJM; 2009 Aug; 102(8):563-8. PubMed ID: 19570990 [TBL] [Abstract][Full Text] [Related]
9. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. Maduwage K; Isbister GK PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841 [TBL] [Abstract][Full Text] [Related]
10. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). Isbister GK; Scorgie FE; O'Leary MA; Seldon M; Brown SG; Lincz LF; J Thromb Haemost; 2010 Nov; 8(11):2504-13. PubMed ID: 20831619 [TBL] [Abstract][Full Text] [Related]
11. Stephen's Banded Snake envenomation treated with tiger snake antivenom. Hession M Emerg Med Australas; 2007 Oct; 19(5):476-8. PubMed ID: 17919222 [TBL] [Abstract][Full Text] [Related]
12. Novel Treatment Strategy for Patients with Venom-Induced Consumptive Coagulopathy from a Pit Viper Bite. Park EJ; Choi S; Kim HH; Jung YS Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32380672 [TBL] [Abstract][Full Text] [Related]
13. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies. Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18). Isbister GK; Buckley NA; Page CB; Scorgie FE; Lincz LF; Seldon M; Brown SG; J Thromb Haemost; 2013 Jul; 11(7):1310-8. PubMed ID: 23565941 [TBL] [Abstract][Full Text] [Related]
15. Catch a tiger snake by its tail: Differential toxicity, co-factor dependence and antivenom efficacy in a procoagulant clade of Australian venomous snakes. Lister C; Arbuckle K; Jackson TNW; Debono J; Zdenek CN; Dashevsky D; Dunstan N; Allen L; Hay C; Bush B; Gillett A; Fry BG Comp Biochem Physiol C Toxicol Pharmacol; 2017 Nov; 202():39-54. PubMed ID: 28757215 [TBL] [Abstract][Full Text] [Related]
16. An examination of the activity of expired and mistreated commercial Australian antivenoms. O'Leary MA; Kornhauser RS; Hodgson WC; Isbister GK Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):937-42. PubMed ID: 19144367 [TBL] [Abstract][Full Text] [Related]
17. Hematologic effects and complications of snake envenoming. Berling I; Isbister GK Transfus Med Rev; 2015 Apr; 29(2):82-9. PubMed ID: 25556574 [TBL] [Abstract][Full Text] [Related]
18. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom. Lane J; O'Leary MA; Isbister GK Toxicon; 2011 Sep; 58(3):239-46. PubMed ID: 21723878 [TBL] [Abstract][Full Text] [Related]
19. Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy. Brown SG; Caruso N; Borland ML; McCoubrie DL; Celenza A; Isbister GK Intensive Care Med; 2009 Sep; 35(9):1532-8. PubMed ID: 19547954 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma. Sprivulis P; Jelinek GA; Marshall L Anaesth Intensive Care; 1996 Jun; 24(3):379-81. PubMed ID: 8805896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]